General MedicationsORALGeneric
METHIMAZOLE
METHIMAZOLE
Standard Dose
20MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview METHIMAZOLE is listed in Drugs@FDA under application 040547 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient METHIMAZOLE Form and strength TABLET;ORAL - 20MG Sponsor AIPING PHARM INC Submission history Latest submission status date: 2019-01-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview METHIMAZOLE is listed in Drugs@FDA under application 040547 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METHIMAZOLE Form and strength TABLET;ORAL - 20MG Sponsor AIPING PHARM INC Submission history Latest submission status date: 2019-01-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.